9th Worldwide Network for Blood and Marrow Transplantation (WBMT) Congress in Ulaanbaatar, Mongolia

25 September 2024 | Nurses Workshop
26 September 2024 | Symposium
27-28 September 2024 | Workshop

This represents a historical event involving global experts, who are known for their efforts to improve health care access and treatment throughout the World. This workshop is a continuation of events pioneered by WBMT, aiming at helping countries with restricted transplant resources and activity. A Nursing hybrid Workshop Program will be included.

Details on registration and the programme will be published here in the coming weeks.

WBMT: The Nigeria BMT Nurses’Post Workshop Webinar 

25 April 2024| 2:00 pm – 3:30 pm CE(S)T | Zoom Webinar

A webinar for previous and first-time attendees as follow up to the Nigeria BMT Nurses Online Workshop intended for all nurses and healthcare workers in the field of Blood and Marrow Transplantation, Hematopoietic Stem Cell Transplantation and Cell Therapy.






03 April 2024| 1:00 pm – 2:00 pm CE(S)T | Zoom Webinar

The Education & Dissemination Committee of the WBMT with chairs Adriana Seber, Damiano Rondelli, and Dietger Niederwieser is organizing a webinar on the topic of NUCLEAR ACCIDENT PREPAREDNESS.





View Recording

Joint Statement on Crisis in Ukraine
The American Society of Transplantation and Cellular Therapy (ASTCT), European Society for Blood Marrow Transplantation (EBMT), and Worldwide Network for Blood Marrow Transplantation (WBMT) firmly condemn the war started by Russian military forces in Ukraine. In particular, ASTCT, EBMT, and WBMT request that peace negotiations prioritize the needs of the most vulnerable Ukrainian people. Casualties among innocent civilians increase by the minute, including children. Patients with severe conditions, such as those with cancer or undergoing life-saving transplants, are currently affected by lack of medications and medical supplies, limited ability to travel to hospitals, lack of adequate nutrition. Healthcare providers and hospital staff in Kyiv remain in their hospitals to treat the patients in shelters, while bombs continue to hit the city.

Read the full letter here.

Stem cell transplantation underutilized for acute myeloid leukemia

Utilization of hematopoietic stem cell transplantation for acute myeloid leukemia has increased over time but remains far below optimal levels, according to study results presented at ASH Annual Meeting and Exposition.

Tokaz spoke with Healio about the study findings and their potential implications, as well as the importance of expanding use of this curative treatment for AML.

Read more and view the recording of the interview by clicking the button below.

View recording

Experts at ASH 2022 Share Global Data on Acute Myeloid Leukemia

In an interview with HCPLive, Tokaz and Force shared expert insight on their investigation and why this worldwide perspective is crucial to progression of oncology research and treatment.

“There’s a mounting global cancer crisis,” Tokaz explained. “By 2040, new cancer diagnoses are expected to double in regions dominated by low-income countrieswhich are the region’s least equipped to deal with this pending cancer epidemic, and by 2040, estimates are that there’ll be over 18 million deaths from cancer worldwide.”

Read more and view the recording of the interview by clicking the button below.

View recording

WBMT is involved in

Global Transplant Activity Data

WBMT conducts annual global surveys of HCT activity performed by transplant centers. The annual survey displays volume of, and main indications for, allogeneic (related, unrelated, and graft source information) and autologous HCT activity. Participate by filling in the reporting sheet. Reporting Sheet


WBMT organizes workshop on a regular base. The workshops are successful in developing transplant programs in Asia, Africa, South America.

Read more

World Health Organization

WBMT is in official relations with the WHO.

Read more


Being part of WBMT is being part of an international community, which helps to optimize the global development of hematopoietic stem cell transplantation.

Mickey Koh
Head of Haematology at St George’s Hospital and Medical School, London, UK